Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1227-1232

  Soto, Daniel E ^a,b   Passarelli, Michael N ^a   Daignault, Stephanie ^a   Sandler, Howard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MGH/North Shore Cancer Center   (United States)

Author keywords

Adjuvant radiotherapy; Androgens; Prostate specific antigen; Prostatic neoplasms; Radiotherapy; Salvage therapy

Indexed keywords

ADJUVANT RADIOTHERAPY; ANDROGENS; PROSTATE SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

ANTIGENS; DISEASES; HAZARDS; MULTIVARIANT ANALYSIS;

RADIOTHERAPY;

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT OUTCOME;

ANDROGEN ANTAGONISTS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84856379786     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.030     Document Type: Article

References (30)

1. M. Han, A.W. Partin, and C.R. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555 565
2. K.A. Roehl, M. Han, and C.G. Ramos Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results J Urol 172 2004 910 914
3. N. Suardi, C.R. Porter, and A.M. Reuther A nomogram predicting long-term biochemical recurrence after radical prostatectomy Cancer 112 2008 1254 1263
4. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
5. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
6. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325-1232
7. S.M. Eulau, D.J. Tate, and T.A. Stamey Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer Int J Radiat Oncol Biol Phys 41 1998 735 740
8. B.W. Corn, K. Winter, and M.V. Pilepich Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group Urology 54 1999 495 502
9. R. Tiguert, J. Rigaud, and L. Lacombe Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level J Urol 170 2003 447 450
10. A. Tewari Management of clinically localized prostate cancer: Pathologic processing to robotic prostatectomy Rev Urol 5 Suppl. 6 2003 S33 S39
11. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial JAMA 296 2006 2329 2335
12. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
13. T. Wiegel, D. Bottke, and N. Willich Phase III results of adjuvant radiotherapy (RT) versus wait and see (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96-02/AUO AP 09/95) J Clin Oncol 23 2005 381
14. J.E. Montie, and M. Hussain Outcomes for radiation therapy after radical prostatectomy for prostate cancer: What really matters? BJU Int 100 2007 485 486
15. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
16. M.V. Pilepich, K. Winter, and M.J. John Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252
17. M.V. Pilepich, K. Winter, and C.A. Lawton Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of phase III RTOG 85-31 Int J Radiat Oncol Biol Phys 61 2005 1285 1290
18. G.E. Hanks, T.F. Pajak, and A. Porter Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02 J Clin Oncol 21 2003 3972 3978
19. M. Roach III, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
20. A.V. D'Amico, J. Manola, and M. Loffredo 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial JAMA 292 2004 821 827
21. M. Bolla, T.M. de Reijke, and A. Zurlo Adjuvant hormone therapy in locally advanced and localized prostate cancer: Three EORTC trials Front Radiat Ther Oncol 36 2002 81 86
22. M.S. Katz, M.J. Zelefsky, and E.S. Venkatraman Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489
23. C.R. King, J.C. Presti Jr., and H. Gill Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes? Int J Radiat Oncol Biol Phys 59 2004 341 347
24. J.A. Freeman, G. Lieskovsky, and G. Grossfeld Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate Urology 44 1994 719 725
25. D.Y. Song, T.L. Thompson, and V. Ramakrishnan Salvage radiotherapy for rising or persistent PSA after radical prostatectomy Urology 60 2002 281 287
26. C. Parker, N. Clarke, and J. Logue RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery) Clin Oncol (R Coll Radiol) 19 2007 167 171
27. L.K. Harle, M. Maggio, and S. Shahani Endocrine complications of androgen-deprivation therapy in men with prostate cancer Clin Adv Hematol Oncol 4 2006 687 696
28. D.P. Lubeck, G.D. Grossfeld, and P.R. Carroll The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer Urology 58 2001 94 100
29. S.J. Feigenberg, A.L. Hanlon, and E.M. Horwitz Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 62 2005 397 405
30. M. Feng, A.L. Hanlon, and T.M. Pisansky Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy Int J Radiat Oncol Biol Phys 68 2007 1417 1423